Operating Lease, Right-of-Use Asset of Kymera Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kymera Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Kymera Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $42,351,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Kymera Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $42,351,000 -$5,056,000 -11% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $42,947,000 -$5,118,000 -11% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $46,045,000 -$2,659,000 -5.5% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $46,734,000 -$2,595,000 -5.3% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $47,407,000 -$5,538,000 -10% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $48,065,000 -$6,890,000 -13% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $48,704,000 -$6,983,000 -13% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $49,329,000 -$7,275,000 -13% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $52,945,000 +$44,036,000 +494% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $54,955,000 +$45,907,000 +507% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $55,687,000 +$46,506,000 +507% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $56,604,000 +$47,297,000 +508% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $8,909,000 -$517,000 -5.5% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $9,048,000 -$492,000 -5.2% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $9,181,000 -$467,000 -4.8% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $9,307,000 -$443,000 -4.5% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $9,426,000 -$419,000 -4.3% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $9,540,000 -$419,000 -4.2% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $9,648,000 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $9,750,000 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $9,845,000 -$8,444,000 -46% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $9,959,000 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q4 2019 $18,289,000 31 Dec 2019 10-K 11 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.